These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 34592709)

  • 1. Antivirals targeting paramyxovirus membrane fusion.
    Contreras EM; Monreal IA; Ruvalcaba M; Ortega V; Aguilar HC
    Curr Opin Virol; 2021 Dec; 51():34-47. PubMed ID: 34592709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly Potent Host-Specific Small-Molecule Inhibitor of Paramyxovirus and Pneumovirus Replication with High Resistance Barrier.
    Shrestha N; Gall FM; Mathieu C; Hierweger MM; Brügger M; Alves MP; Vesin J; Banfi D; Kalbermatter D; Horvat B; Chambon M; Turcatti G; Fotiadis D; Riedl R; Plattet P
    mBio; 2021 Dec; 12(6):e0262121. PubMed ID: 34724816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of Cholesterol in Early and Late Steps of the Nipah Virus Membrane Fusion Cascade.
    Contreras EM; Johnston GP; Buchholz DW; Ortega V; Monreal IA; Zamora JLR; Cheung T; Aguilar HC
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33408170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitazoxanide inhibits paramyxovirus replication by targeting the Fusion protein folding: role of glycoprotein-specific thiol oxidoreductase ERp57.
    Piacentini S; La Frazia S; Riccio A; Pedersen JZ; Topai A; Nicolotti O; Rossignol JF; Santoro MG
    Sci Rep; 2018 Jul; 8(1):10425. PubMed ID: 29992955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Third Helical Domain of the Nipah Virus Fusion Glycoprotein Modulates both Early and Late Steps in the Membrane Fusion Cascade.
    Zamora JLR; Ortega V; Johnston GP; Li J; André NM; Monreal IA; Contreras EM; Whittaker GR; Aguilar HC
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32669342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of paramyxovirus membrane fusion and virus entry.
    Jardetzky TS; Lamb RA
    Curr Opin Virol; 2014 Apr; 5():24-33. PubMed ID: 24530984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Broad spectrum antiviral activity for paramyxoviruses is modulated by biophysical properties of fusion inhibitory peptides.
    Mathieu C; Augusto MT; Niewiesk S; Horvat B; Palermo LM; Sanna G; Madeddu S; Huey D; Castanho MA; Porotto M; Santos NC; Moscona A
    Sci Rep; 2017 Mar; 7():43610. PubMed ID: 28344321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paramyxovirus Glycoproteins and the Membrane Fusion Process.
    Aguilar HC; Henderson BA; Zamora JL; Johnston GP
    Curr Clin Microbiol Rep; 2016 Sep; 3(3):142-154. PubMed ID: 28138419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural Insight into Paramyxovirus and Pneumovirus Entry Inhibition.
    Aggarwal M; Plemper RK
    Viruses; 2020 Mar; 12(3):. PubMed ID: 32245118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parainfluenza virus entry at the onset of infection.
    Marcink TC; Porotto M; Moscona A
    Adv Virus Res; 2021; 111():1-29. PubMed ID: 34663496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shared paramyxoviral glycoprotein architecture is adapted for diverse attachment strategies.
    Bowden TA; Crispin M; Jones EY; Stuart DI
    Biochem Soc Trans; 2010 Oct; 38(5):1349-55. PubMed ID: 20863312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and evaluation of a highly effective fusion inhibitor for human metapneumovirus.
    Deffrasnes C; Hamelin ME; Prince GA; Boivin G
    Antimicrob Agents Chemother; 2008 Jan; 52(1):279-87. PubMed ID: 17967906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paramyxovirus membrane fusion: lessons from the F and HN atomic structures.
    Lamb RA; Paterson RG; Jardetzky TS
    Virology; 2006 Jan; 344(1):30-7. PubMed ID: 16364733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measles Virus Fusion Protein: Structure, Function and Inhibition.
    Plattet P; Alves L; Herren M; Aguilar HC
    Viruses; 2016 Apr; 8(4):112. PubMed ID: 27110811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple Strategies Reveal a Bidentate Interaction between the Nipah Virus Attachment and Fusion Glycoproteins.
    Stone JA; Vemulapati BM; Bradel-Tretheway B; Aguilar HC
    J Virol; 2016 Dec; 90(23):10762-10773. PubMed ID: 27654290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The three faces of paramyxovirus attachment proteins.
    Morrison TG
    Trends Microbiol; 2001 Mar; 9(3):103-5. PubMed ID: 11239770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Roles of the N1 Loop and N4 Alpha-Helical Region of the Nipah Virus Fusion Glycoprotein in Modulating Early and Late Steps of the Membrane Fusion Cascade.
    Zamora JLR; Ortega V; Johnston GP; Li J; Aguilar HC
    J Virol; 2021 Apr; 95(9):. PubMed ID: 33568505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unity in diversity: shared mechanism of entry among paramyxoviruses.
    Palgen JL; Jurgens EM; Moscona A; Porotto M; Palermo LM
    Prog Mol Biol Transl Sci; 2015; 129():1-32. PubMed ID: 25595799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibiting Human Parainfluenza Virus Infection by Preactivating the Cell Entry Mechanism.
    Bottom-Tanzer SF; Rybkina K; Bell JN; Alabi CA; Mathieu C; Lu M; Biswas S; Vasquez M; Porotto M; Melero JA; Más V; Moscona A
    mBio; 2019 Feb; 10(1):. PubMed ID: 30782664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholesterol reducing agents inhibit assembly of type I parainfluenza viruses.
    Bajimaya S; Hayashi T; Frankl T; Bryk P; Ward B; Takimoto T
    Virology; 2017 Jan; 501():127-135. PubMed ID: 27915128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.